Paul N. Span
Department of Chemical Endocrinology
Radboud University Nijmegen Medical Centre
Nijmegen
Netherlands
Name/email consistency: high
- Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology Group. Span, P.N., Sieuwerts, A.M., Heuvel, J.J., Spyratos, F., Duffy, M.J., Eppenberger-Castori, S., Vacher, S., O'Brien, K., McKiernan, E., Pierce, A., Vuaroqueaux, V., Foekens, J.A., Sweep, F.C., Martens, J.W. Eur. J. Cancer (2009)
- Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. Span, P.N., Witjes, J.A., Grebenchtchikov, N., Geurts-Moespot, A., Moonen, P.M., Aalders, T.W., Vriesema, J.L., Kiemeney, L.A., Schalken, J.A., Sweep, F.C. BJU Int. (2008)
- High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Span, P.N., Tjan-Heijnen, V.C., Manders, P., van Tienoven, D., Lehr, J., Sweep, F.C. Breast Cancer Res. Treat. (2006)
- Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?. Span, P.N., Tjan-Heijnen, V.C., Heuvel, J.J., de Kok, J.B., Foekens, J.A., Sweep, F.C. Clin. Chem. (2006)
- Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. Span, P.N., Waanders, E., Manders, P., Heuvel, J.J., Foekens, J.A., Watson, M.A., Beex, L.V., Sweep, F.C. J. Clin. Oncol. (2004)
- Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Span, P.N., Sweep, F.C., Wiegerinck, E.T., Tjan-Heijnen, V.C., Manders, P., Beex, L.V., de Kok, J.B. Clin. Chem. (2004)
- Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Span, P.N., Sweep, C.G., Manders, P., Beex, L.V., Leppert, D., Lindberg, R.L. Cancer (2003)
- E1AF expression levels are not associated with prognosis in human breast cancer. Span, P.N., Manders, P., Heuvel, J.J., Beex, L.V., Sweep, C.G. Breast Cancer Res. Treat. (2003)
- Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Span, P.N., Bussink, J., Manders, P., Beex, L.V., Sweep, C.G. Br. J. Cancer (2003)
- Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Span, P.N., Tjan-Heijnen, V.C., Manders, P., Beex, L.V., Sweep, C.G. Oncogene (2003)
